US EditionOSPRI Launches as Vertically-Integrated Biotech Company with $30M
Summary by hitconsultant.net
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
OSPRI Launches as Vertically-Integrated Biotech Company with $30M
What You Should Know: – Community Direct DX (CDx), Scienetix, and the R&D division of Advanta Genetics have merged to form OSPRI, a new biotechnology company specializing in polymerase chain reaction (PCR)-based infectious disease detection. – The merger creates one of the world’s first fully vertically-integrated molecular testing platforms. Addressing Cost and Complexity in PCR Testing OSPRI will develop and deliver advanced tools to improve…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
